Leveraging Nuclear Receptors as Targets for Pathological Ocular Vascular Diseases.

Journal Article (Journal Article;Review)

Vasculogenesis and angiogenesis are physiological mechanisms occurring throughout the body. Any disruption to the precise balance of blood vessel growth necessary to support healthy tissue, and the inhibition of abnormal vessel sprouting has the potential to negatively impact stages of development and/or healing. Therefore, the identification of key regulators of these vascular processes is critical to identifying therapeutic means by which to target vascular-associated compromises and complications. Nuclear receptors are a family of transcription factors that have been shown to be involved in modulating different aspects of vascular biology in many tissues systems. Most recently, the role of nuclear receptors in ocular biology and vasculopathies has garnered interest. Herein, we review studies that have used in vitro assays and in vivo models to investigate nuclear receptor-driven pathways in two ocular vascular diseases associated with blindness, wet or exudative age-related macular degeneration, and proliferative diabetic retinopathy. The potential therapeutic targeting of nuclear receptors for ocular diseases is also discussed.

Full Text

Duke Authors

Cited Authors

  • Yao, P-L; Peavey, J; Malek, G

Published Date

  • April 21, 2020

Published In

Volume / Issue

  • 21 / 8

PubMed ID

  • 32326149

Pubmed Central ID

  • PMC7215709

Electronic International Standard Serial Number (EISSN)

  • 1422-0067

Digital Object Identifier (DOI)

  • 10.3390/ijms21082889


  • eng

Conference Location

  • Switzerland